219 related articles for article (PubMed ID: 22322899)
1. Inclusion complex of novel curcumin analogue CDF and β-cyclodextrin (1:2) and its enhanced in vivo anticancer activity against pancreatic cancer.
Dandawate PR; Vyas A; Ahmad A; Banerjee S; Deshpande J; Swamy KV; Jamadar A; Dumhe-Klaire AC; Padhye S; Sarkar FH
Pharm Res; 2012 Jul; 29(7):1775-86. PubMed ID: 22322899
[TBL] [Abstract][Full Text] [Related]
2. Characterization of the host-guest complex of a curcumin analog with β-cyclodextrin and β-cyclodextrin-gemini surfactant and evaluation of its anticancer activity.
Poorghorban M; Das U; Alaidi O; Chitanda JM; Michel D; Dimmock J; Verrall R; Grochulski P; Badea I
Int J Nanomedicine; 2015; 10():503-15. PubMed ID: 25609956
[TBL] [Abstract][Full Text] [Related]
3. Preparation of curcumin-hydroxypropyl-β-cyclodextrin inclusion complex by cosolvency-lyophilization procedure to enhance oral bioavailability of the drug.
Li N; Wang N; Wu T; Qiu C; Wang X; Jiang S; Zhang Z; Liu T; Wei C; Wang T
Drug Dev Ind Pharm; 2018 Dec; 44(12):1966-1974. PubMed ID: 30059244
[TBL] [Abstract][Full Text] [Related]
4. beta-Cyclodextrin-curcumin self-assembly enhances curcumin delivery in prostate cancer cells.
Yallapu MM; Jaggi M; Chauhan SC
Colloids Surf B Biointerfaces; 2010 Aug; 79(1):113-25. PubMed ID: 20456930
[TBL] [Abstract][Full Text] [Related]
5. Anticancer Activity of Novel Difluorinated Curcumin Analog and Its Inclusion Complex with 2-Hydroxypropyl-β-Cyclodextrin against Pancreatic Cancer.
Bhattacharyya S; Ghosh H; Covarrubias-Zambrano O; Jain K; Swamy KV; Kasi A; Hamza A; Anant S; VanSaun M; Weir SJ; Bossmann SH; Padhye SB; Dandawate P
Int J Mol Sci; 2023 Mar; 24(7):. PubMed ID: 37047307
[TBL] [Abstract][Full Text] [Related]
6. Curcumin-cyclodextrin complexes enhanced the anti-cancer effects of curcumin.
Zhang L; Man S; Qiu H; Liu Z; Zhang M; Ma L; Gao W
Environ Toxicol Pharmacol; 2016 Dec; 48():31-38. PubMed ID: 27716533
[TBL] [Abstract][Full Text] [Related]
7. Parenterally administrable nano-micelles of 3,4-difluorobenzylidene curcumin for treating pancreatic cancer.
Kesharwani P; Banerjee S; Padhye S; Sarkar FH; Iyer AK
Colloids Surf B Biointerfaces; 2015 Aug; 132():138-45. PubMed ID: 26037703
[TBL] [Abstract][Full Text] [Related]
8. Difluorinated Curcumin: A Promising Curcumin Analogue with Improved Anti-Tumor Activity and Pharmacokinetic Profile.
Momtazi AA; Sahebkar A
Curr Pharm Des; 2016; 22(28):4386-97. PubMed ID: 27229723
[TBL] [Abstract][Full Text] [Related]
9. The Antitumoral Effect In Ovo of a New Inclusion Complex from Dimethoxycurcumin with Magnesium and Beta-Cyclodextrin.
Obregón-Mendoza MA; Meza-Morales W; Rodríguez-Hernández KD; Estévez-Carmona MM; Pérez-González LL; Tavera-Hernández R; Ramírez-Apan MT; Barrera-Hernández D; García-Olivares M; Monroy-Torres B; Nieto-Camacho A; Chávez MI; Sánchez-Obregón R; Enríquez RG
Int J Mol Sci; 2024 Apr; 25(8):. PubMed ID: 38673967
[TBL] [Abstract][Full Text] [Related]
10. Fluorocurcumins as cyclooxygenase-2 inhibitor: molecular docking, pharmacokinetics and tissue distribution in mice.
Padhye S; Banerjee S; Chavan D; Pandye S; Swamy KV; Ali S; Li J; Dou QP; Sarkar FH
Pharm Res; 2009 Nov; 26(11):2438-45. PubMed ID: 19714451
[TBL] [Abstract][Full Text] [Related]
11. Long-Circulating Curcumin-Loaded Liposome Formulations with High Incorporation Efficiency, Stability and Anticancer Activity towards Pancreatic Adenocarcinoma Cell Lines In Vitro.
Mahmud M; Piwoni A; Filipczak N; Janicka M; Gubernator J
PLoS One; 2016; 11(12):e0167787. PubMed ID: 27936114
[TBL] [Abstract][Full Text] [Related]
12. Synthesis and characterization of folate decorated albumin bio-conjugate nanoparticles loaded with a synthetic curcumin difluorinated analogue.
Gawde KA; Kesharwani P; Sau S; Sarkar FH; Padhye S; Kashaw SK; Iyer AK
J Colloid Interface Sci; 2017 Jun; 496():290-299. PubMed ID: 28236692
[TBL] [Abstract][Full Text] [Related]
13. Targeted anticancer prodrug therapy using dextran mediated enzyme-antibody conjugate and β-cyclodextrin-curcumin inclusion complex.
Roozbehi S; Dadashzadeh S; Mirshahi M; Sadeghizadeh M; Sajedi RH
Int J Biol Macromol; 2020 Oct; 160():1029-1041. PubMed ID: 32479931
[TBL] [Abstract][Full Text] [Related]
14. Characterization and evaluation of a folic acid receptor-targeted cyclodextrin complex as an anticancer drug delivery system.
Xu J; Xu B; Shou D; Qin F; Xu Y; Hu Y
Eur J Pharm Sci; 2016 Feb; 83():132-42. PubMed ID: 26577995
[TBL] [Abstract][Full Text] [Related]
15. Native and β-cyclodextrin-enclosed curcumin: entrapment within liposomes and their in vitro cytotoxicity in lung and colon cancer.
Rahman S; Cao S; Steadman KJ; Wei M; Parekh HS
Drug Deliv; 2012; 19(7):346-53. PubMed ID: 23030405
[TBL] [Abstract][Full Text] [Related]
16. Curcumin-C3 Complexed with α-, β-cyclodextrin Exhibits Antibacterial and Antioxidant Properties Suitable for Cancer Treatments.
Reddy DNK; Kumar R; Wang SP; Huang FY
Curr Drug Metab; 2019; 20(12):988-1001. PubMed ID: 31573881
[TBL] [Abstract][Full Text] [Related]
17. Inclusion complex of erlotinib with sulfobutyl ether-β-cyclodextrin: Preparation, characterization, in silico, in vitro and in vivo evaluation.
Devasari N; Dora CP; Singh C; Paidi SR; Kumar V; Sobhia ME; Suresh S
Carbohydr Polym; 2015 Dec; 134():547-56. PubMed ID: 26428157
[TBL] [Abstract][Full Text] [Related]
18. An optimized molecular inclusion complex of diferuloylmethane: enhanced physical properties and biological activity.
Tan Q; Li Y; Wu J; Mei H; Zhao C; Zhang J
Int J Nanomedicine; 2012; 5():5385-93. PubMed ID: 23091376
[TBL] [Abstract][Full Text] [Related]
19. Preparation, characteristic and pharmacological study on inclusion complex of sulfobutylether-β-cyclodextrin with glaucocalyxin A.
Ren L; Jing J; Chen G; Miao Y; Wei P
J Pharm Pharmacol; 2014 Jul; 66(7):927-34. PubMed ID: 24697809
[TBL] [Abstract][Full Text] [Related]
20. Design and evaluation of cyclodextrin-based delivery systems to incorporate poorly soluble curcumin analogs for the treatment of melanoma.
Michel D; Chitanda JM; Balogh R; Yang P; Singh J; Das U; El-Aneed A; Dimmock J; Verrall R; Badea I
Eur J Pharm Biopharm; 2012 Aug; 81(3):548-56. PubMed ID: 22531300
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
